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Abstract
In this prospective cohort study for Japanese patients with established ischemic heart disease
(IHD), the authors investigated the rate of success of smoking cessation 3 months after hospital
discharge and its related factors. The subjects included 90 current smokers admitted for IHD. A
total of 58 subjects (64%) had quit smoking for 3 months after being discharged. In comparison
with subjects with acute myocardial infarction, those with stable angina (SA) showed a signifi-
cantly lower frequency of smoking cessation (relative risk of resuming smoking (95% confidence
interval):2.06 (1.09, 3.92), p=0.036). This relationship remained significant even after controlling
for sex, age, and scores of the Fagerstrom Test for Nicotine Dependence (adjusted odds ratio:3.39
(1.01, 11.37), p=0.048). However, it became insignificant when hospital admission followed by
emergency medical service (EMS) care was additionally adjusted (adjusted odds ratio:2.48 (0.36,
16.97), p=0.356). The smoking cessation rate in this study was identical to that observed in studies
conducted in Japan prior to the recent social changes with regard to tobacco use. SA still appears
to be a risk factor for smoking resumption after discharge. Experiencing EMS care would be an
intermediate variable in this relationship.
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n Japan,  the in-hospital mortality rate among 
patients with acute myocardial infarction (AMI) 
is currently calculated to be less than 10ｵ [1ﾝ3].  
Very few patients with angina die in the hospital.  
Consequently,  preventive approaches against recur-
rence and deterioration are crucial for patients with 
ischemic heart disease (IHD),  i.e.,  myocardial infarc-
tion and angina.  For this purpose,  the cessation of 
smoking is essential for all IHD patients [4].  Meta-
analysis reports have demonstrated that the beneﬁts of 
smoking cessation in established IHD patients are 
extended life expectancy and decreased onset of car-
diac events [5ﾝ7].
　 It has been reported that 26ｵ―66ｵ of IHD        
inpatients resume smoking within 3 months to 1 year 
after hospital discharge [8ﾝ14].  The varied results 
can be attributed to diﬀerences in patient characteris-
tics among the studies.  On the other hand,  it has been 
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reported that the prevalence of smoking in some coun-
tries diminishes after introducing amendments to 
health policies with regard to tobacco such as an 
increase in the price of tobacco products,  the intro-
duction of warning labels on such product packages,  
and restrictions on smoking in public places [15].  
Japan has made some signiﬁcant changes with regard 
to health policies concerning tobacco use for these 
years.  Cigarette taxes have increased by approxi-
mately 25ｵ over the past 5 years,  according to a 
report by the Ministry of Finance (http://www.mof.
go.jp/jouhou/syuzei/siryou/128.  htm; accessed Oct.  
23,  2007).  In accordance with the World Health 
Organization Framework Convention on Tobacco 
Control (WHO-FCTC) [16,  17],  warnings pertaining 
to the harmful eﬀects of smoking have been printed on 
all tobacco packages since 2005.  The Health 
Promotion Law (HPL),  which was the ﬁrst legislation 
to deﬁne and control passive smoking in public places,  
was enforced in 2003 [16].  Therefore,  comparing 
past and present trends in the smoking status of IHD 
patients after hospital discharge is a worthwhile exer-
cise.
　 Review reports have suggested that smoking cessa-      
tion interventions increase the number of IHD patients 
who successfully quit smoking by as much as 50ｵ [5,  
18].  Further improvements must be undertaken so 
that all established IHD patients quit smoking [4].  
For this purpose,  it is worthwhile to elucidate the 
characteristics of IHD patients who have diﬃculty in 
achieving smoking cessation.  However,  previous stu-
dies examining the relationships between smoking ces-
sation and sex,  age,  prehospitalization smoking habits,  
and clinical ﬁndings have revealed mixed results [8,  
9,  11ﾝ14,  19ﾝ21].  Further,  only a few such studies 
have been carried out in Japan [12,  13].
　 In this prospective cohort study, the authors exam-       
ined the rate of success of smoking abstinence for 3 
months after hospital discharge and whether sex,  age,  
prehospitalization smoking habits,  and clinical ﬁndings 
were related to the smoking status of Japanese IHD 
inpatients.
Subjects and Methods
　 Subjects. The subjects were recruited at a 
general hospital in Kochi,  Japan,  from April 2005 to 
August 2006.  The inclusion criteria for the study 
were admission for AMI,  unstable angina (UA),  or 
stable angina (SA) and a declaration of daily smoking 
by the inpatient.  Medical doctors and nurses in the 
hospital explained the study protocol to eligible inpa-
tients before obtaining written informed consent.  A 
total of 100 inpatients participated in this study.  
Information regarding smoking status after discharge 
was not obtained from 10 (nonfollowed) participants 
for the following reasons: 1 patient expired within 3 
months of hospital discharge,  and 9 patients could not 
be contacted due to a change in residence.  The 
remaining 90 patients were regarded as the subjects 
of the study.
　 No standardized support program for smoking ces-      
sation was set for the present study.  The subjects 
were given verbal instructions for smoking cessation 
by the medical doctors and nurses; these instructions 
were occasionally accompanied by leaﬂets.  The doc-
tors and nurses exercised their discretion with regard 
to determining the content and frequency of the 
instructions during the hospitalization.
　 Study variables. Sex,  age,  and the clinical 
ﬁndings of the patients were compiled from medical 
records.  The clinical ﬁndings included past IHD his-
tory,  diagnosis (AMI,  UA,  or SA),  the number of 
diseased coronary arteries,  peak creatine phos-
phokinase (CPK) levels,  the instances of hospital 
admission followed by emergency medical service 
(EMS) care,  the length of hospitalization,  subjective 
symptoms at the time of admission (chest pain and 
dyspnea),  the Killip classiﬁcation [22] at the time of 
admission,  and the performance of percutaneous coro-
nary intervention (PCI) [23] or coronary artery 
bypass grafting (CABG) [24].  The patients were 
diagnosed by cardiologists certiﬁed by the Japanese 
Circulation Society.  A diseased coronary artery was 
deﬁned as one exhibiting stenosis of 75ｵ or greater 
as determined by coronary angiography.  Data on the 
Killip classiﬁcation and peak CPK levels were 
obtained only from participants with AMI.
　 In order to obtain information on prehospitaliza-      
tion smoking habits,  the nurses interviewed the sub-
jects as soon as their condition stabilized.  The sub-
jects were questioned regarding the number of ciga-
rettes smoked per day,  the number of years of smok-
ing,  and the degree of nicotine dependence.  The 
degree of nicotine dependence was evaluated using 2 
self-reported questionnaires: the Fagerstrom Test for 
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Nicotine Dependence [25] and the Tobacco Depend-
ence Screener [26].  For both questionnaires,  a 
greater score implies a heavier dependence.  Smoking 
cessation guidance was not provided when collecting 
the information; therefore,  the subjects provided a 
frank declaration of their smoking history.
　 To determine the smoking status 3 months after        
hospital discharge,  one of the authors (A. O. ) tele-
phoned the subjects and inquired whether they had 
abstained from smoking.  The subjects who replied 
aﬃrmatively were considered as abstainers.  The oth-
ers were regarded as nonabstainers.
　 Ethics. The present study was carried out in 
accordance with the approval of the Ethical 
Committees of the hospital at which the present study 
was performed and Kochi Medical School.
　 Statistical analysis. The subjectsʼ baseline 
characteristics were compared with their diagnoses 
using the chi-square test and one-way analysis of vari-
ance.  The diﬀerence in the baseline characteristics 
was investigated between the subjects and the nonfol-
lowed participants using Fisherʼs exact test and the 
t-test.  The relationships between the smoking status 3 
months after hospital discharge and sex,  age,  prehos-
pitalization smoking habits,  and clinical ﬁndings were 
evaluated based on the relative risk of resuming smok-
ing or diﬀerences in the mean value of each baseline 
characteristic between abstainers and nonabstainers.  
For the variables that showed an association with the 
smoking status after discharge,  multiple logistic 
regression analysis was performed to control possible 
confounders.  The level of signiﬁcance was 0. 05 
(2-tailed) for all tests.  Calculations were performed 
using SPSSⓇ 13.0J for Windows (SPSS Japan Inc.,  
Tokyo,  Japan).
Results
　 The baseline characteristics of the subjects are       
summarized in Table 1.  Compared with subjects with 
AMI or UA,  SA subjects exhibited the following fea-
tures: fewer arteries with stenosis,  fewer instances 
of admission followed by EMS care,  a shorter dura-
tion of hospitalization,  and a lower frequency of chest 
pain complaints at the time of admission; further,  a 
fewer number of SA subjects compared with the AMI 
or UA patients underwent PCI or CABG.  There were 
no signiﬁcant diﬀerences in any of the baseline vari-
ables between the subjects and the nonfollowed par-
ticipants (data not shown).
　 Of the 90 subjects, 64ｵ abstained from smoking        
for 3 months after discharge.
　 Table 2 indicates the relationship between the     
smoking status after hospital discharge and sex,  age,  
prehospitalization smoking habits,  and clinical ﬁnd-
ings.  In comparison with the subjects with AMI,  those 
with SA showed a signiﬁcantly lower frequency of 
smoking cessation.  The negative relationship between 
admission followed by EMS care and smoking resump-
tion after discharge showed borderline signiﬁcance.  
The other variables revealed no signiﬁcant relation-
ship with smoking status after discharge.  
　 The results of multiple logistic regression analysis       
are given in Table 3.  The relationship between SA 
and resuming smoking after discharge was signiﬁcant 
even after controlling for sex,  age,  and the FTND 
score.  However,  it became insigniﬁcant when admis-
sion followed by EMS care was additionally adjusted.
Discussion
　 The smoking cessation rate observed in the present        
study resembles that observed in 2 previous Japanese 
studies.  A Japanese prospective cohort study found 
that 66ｵ of IHD inpatients quit smoking for 6 months 
after discharge [12].  Another study reported that 
74ｵ of AMI inpatients remained abstinent for 3 
months after hospital discharge [13].  Previous stud-
ies indicated that patients with SA showed a lower 
frequency of smoking cessation than those with AMI 
or UA [11,  14,  19]; this result was also obtained in 
the present study.  However,  the results of this study 
were based on patients from just 1 hospital.  Multi-
institutional surveys are indispensable in order to 
generalize the ﬁndings of the present study.  
Furthermore,  based on the present ﬁndings,  we can-
not conclude whether the recent changes in Japanese 
health policies with regard to tobacco use,  as men-
tioned in the Introduction,  modiﬁed the smoking 
behaviors of the subjects,  as the eﬀect of such 
changes on each subject was not assessed.  By refer-
ring to previous reports indicating a possible relation-
ship between health policies and the prevalence of 
smoking [15],  researchers need to establish absolute 
methods to evaluate the impact of health policies on 
individuals.  This would help in future investigations 
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to comprehensively clarify correlates of smoking 
behavior among established IHD patients.
　 In comparison with the subjects with AMI,  those 
with SA quit smoking less frequently.  This result is 
concordant with those from previous studies in 
Western countries [11,  14,  19].
　 Scholte op Reimer et al.  [14] have pointed out the 
possibility that AMI patients are keener than patients 
who have only experienced nonfatal ischemic episodes 
to realize the seriousness of their disease and are 
more willing to accept recommendations for lifestyle 
changes.  Based on the present results of multiple 
logistic regression analysis,  the authors supposed that 
experiencing EMS care could contribute toward this 
diﬀerence.  In this study,  admission followed by EMS 
care was associated with both the diagnosis and smok-
ing resumption after discharge.  Thus,  admission fol-
lowed by EMS care was entered in the multiple logis-
tic regression analysis.  An intermediate variable is 
epidemiologically deﬁned as one that causes variation 
in the dependent variable and is caused to vary by the 
independent variables [27].  The results of multiple 
logistic regression analysis suggested that taking EMS 
care is an intermediate variable in the relationship 
between diagnosis and the smoking status after dis-
charge.
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Table 1　　Baseline characteristics of the subjects: comparison with the diagnosis at the time of admission
Variables








Sex: Male 49 (89ｵ) 18 (90ｵ) 14 (93ｵ) 0.889
Age 62.4 (10.9) 63.3 ( 9.4) 64.2 (5.6) 0.801
No.  of cigarettes smoked per day
　10 or less 12 (22ｵ) 5 (25ｵ) 7 (47ｵ)
　11‒20 18 (33ｵ) 5 (25ｵ) 1 ( 7ｵ)
0.138
　21‒30 16 (29ｵ) 6 (30ｵ) 7 (47ｵ)
　31 or more 9 (16ｵ) 4 (20ｵ) 0 ( 0ｵ)
No.  of years of smoking 42.6 (11.8) 42.7 (11.3) 46.1 (5.5) 0.535
Score of nicotine dependence
　FTND 5.5 ( 2.6) 5.5 ( 2.4) 6.1 (2.2) 0.707
　TDS 6.0 ( 2.4) 5.9 ( 3.0) 6.9 (2.4) 0.465
Positive past history of IHD 10 (18ｵ) 7 (35ｵ) 6 (40ｵ) 0.125
No.  of diseased coronary arteries
　0 1 ( 2ｵ) 4 (20ｵ) 5 (33ｵ)
　1 29 (53ｵ) 8 (40ｵ) 6 (40ｵ)
0.027
　2 17 (31ｵ) 5 (25ｵ) 3 (20ｵ)
　3 8 (15ｵ) 3 (15ｵ) 1 ( 7ｵ)
Peak CPK (IU/l)b) 2,701 (2,522)
Admission followed by EMS care 53 (97ｵ) 15 (75ｵ) 1 ( 7ｵ) < 0.001
No.  of hospitalization days 17.7 ( 7.0) 8.1 ( 5.7) 7.2 (8.9) < 0.001
Suﬀering chest pain at admission 43 (78ｵ) 15 (75ｵ) 6 (40ｵ) 0.014
Suﬀering dyspnea at admission 9 (16ｵ) 2 (10ｵ) 2 (13ｵ) 0.779
Killip classiﬁcation at admission b)
　1 52 (95ｵ)
　2 2 ( 4ｵ)
　3 0 ( 0ｵ)
　4 1 ( 2ｵ)
Taking PCI or CABG 51 (93ｵ) 17 (85ｵ) 8 (53ｵ) 0.001
a) Calculated using the chi-square test or one-way analysis of variance.
b) Data were obtained only from subjects with AMI (n=55).
AMI , acute myocardial infarction; UA , unstable angina: SA , stable angina; FTND , Fagerstrom Test for Nicotine Dependence; TDS , 
Tobacco Dependence Screener; IHD , ischemic heart disease; CPK , creatine phosphokinase; EMS , emergency medical service; PCI , 
percutaneous coronary intervention ; CABG , coronary artery bypass grafting .
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　 It could be possible that the relationship between 
SA and smoking resumption after discharge merely 
reﬂected the heterogeneity of the nature of smoking 
cessation support during the hospitalization.  No stan-
dardized support program for smoking cessation was 
prepared for this study.  Moreover,  determining the 
content and frequency of support for smoking cessa-
tion was left exclusively to the discretion of the medi-
cal doctors and nurses who were in charge of the 
subjects.  Consequently,  the instructions for smoking 
cessation during the hospitalization might diﬀer 
between subjects.  Compared to the subjects with SA,  
155Smoking Cessation among IHD PatientsJune 2008
Table 2　　Relationship between smoking status 3 months after hospital discharge and sex,  age,  prehospitalization smoking habits,  and 
clinical ﬁndings (N=90)
Variables
Frequency (ｵ) or mean (SD)
Relative risk or difference





Sex Female 3 (33ｵ) 6 ( 67ｵ) 1.00 c)
Male 29 (36ｵ) 52 ( 64ｵ) 1.07 (0.33, 3.46) 1.000
Age 63.0 ( 9.6) 62.8 (10.0) 0.16 (－4.16, 4.48) 0.942
No.  of cigarettes smoked per day 10 or less 4 (31ｵ) 9 ( 69ｵ) 1.00 c)
11‒20 11 (38ｵ) 18 ( 62ｵ) 1.23 (0.42, 3.65) 0.739
21‒30 6 (25ｵ) 18 ( 75ｵ) 0.81 (0.24, 2.70) 1.000
31 or more 11 (46ｵ) 13 ( 54ｵ) 1.49 (0.51, 4.35) 0.491
No.  of years of smoking 42.4 (11.3) 43.6 (10.7) －1.26 (－6.03, 3.50) 0.599
Score of nicotine dependence FTND 6.0 ( 2.3) 5.3 ( 2.5) 0.70 (－0.38, 1.78) 0.199
TDS 6.6 ( 2.4) 5.9 ( 2.6) 0.71 (－0.39, 1.81) 0.200
Past history of IHD Negative 22 (37ｵ) 45 ( 63ｵ) 1.00 c)
Positive 10 (43ｵ) 13 ( 57ｵ) 1.32 (0.71, 2.48) 0.450
Diagnosis AMI 16 (29ｵ) 39 ( 71ｵ) 1.00 c)
UA 7 (35ｵ) 13 ( 65ｵ) 1.20 (0.56, 2.61) 0.778
SA 9 (60ｵ) 6 ( 40ｵ) 2.06 (1.09, 3.92) 0.036
No.  of diseased coronary arteries 0 3 (30ｵ) 7 ( 70ｵ) 1.00 c)
1 15 (35ｵ) 28 ( 65ｵ) 1.25 (0.28, 5.55) 1.000
2 10 (40ｵ) 15 ( 60ｵ) 1.56 (0.32, 7.49) 0.709
3 4 (33ｵ) 8 ( 67ｵ) 1.17 (0.19, 7.12) 1.000
Peak CPK (IU/l) d) 2,107 (2,203) 2,945 (2,630) －837.7 (－2336.0, 660.7) 0.267
Admission followed by EMS care Not applicable 11 (52ｵ) 10 ( 48ｵ) 1.00 c)
Applicable 21 (30ｵ) 48 ( 69ｵ) 0.58 (0.29, 1.16) 0.075
No.  of hospitalization days 12.6 ( 9.2) 14.5 ( 8.2) －1.82 (－5.57, 1.92) 0.336
Chest pain at admission Not suffering 8 (31ｵ) 18 ( 69ｵ) 1.00 c)
Suffering 24 (37ｵ) 40 ( 63ｵ) 1.22 (0.57, 2.61) 0.631
Dyspnea at admission Not suffering 28 (36ｵ) 49 ( 64ｵ) 1.00 c)
Suffering 4 (31ｵ) 9 ( 69ｵ) 0.85 (0.35, 2.07) 0.765
Killip classification at admission d) 1 16 (31ｵ) 36 ( 69ｵ) uncalculated
2‒4 0 ( 0ｵ) 3 (100ｵ)
PCI or CABG Not taken 3 (21ｵ) 11 ( 79ｵ) 1.00 c)
　 Taken 29 (38ｵ) 47( 62ｵ) 1.78 (0.55, 5.72) 0.362
a) The relative risk of resuming smoking and the difference in the mean values between abstainers and nonabstainers are calculated for 
categorical and continuous variables,  respectively.
b) Calculated with Fisherʼs exact test or t-test.
c) Reference
d) Data were obtained only from the subjects with AMI (n = 55).
FTND,  Fagerstrom Test for Nicotine Dependence; TDS,  Tobacco Dependence Screener; IHD,  ischemic heart disease; AMI,  acute 
myocardial infarction; UA,  unstable angina; SA,  stable angina; CPK, creatine phosphokinase; EMS,  emergency medical service; PCI,  
percutaneous coronary intervention; CABG,  coronary artery bypass grafting.
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those with AMI might be provided with stricter and 
more frequent instructions to quit smoking; this 
approach could lead to higher smoking cessation rates 
among the subjects with AMI.  However,  it was not 
evaluated in this study whether there were any diﬀer-
ences in the smoking cessation instructions between 
subjects.  Hence,  the authors could not investigate 
further.
　 The authors discuss here whether the smoking sta-       
tus after discharge was correctly assessed in this 
study.  Self-reported smoking status is generally 
thought to be reliable [28,  29].  On the other hand,  in 
a survey by Ockene et al.  [10],  30ｵ―40ｵ of IHD 
patients who self-reported smoking cessation after 
discharge were judged to be smokers by the estima-
tion of saliva cotinine,  a metabolite of nicotine.  
Therefore,  it is possible that the smoking cessation 
rate was overestimated in the present study.
　 Certain limitations in the present study should be        
taken into account while interpreting the results.  The 
sample size in this study may not be large enough to 
detect the eﬀects of sex,  age,  and prehospitalization 
smoking habits on smoking behaviors after discharge.  
Certain unexamined factors in this study,  e.g., genetic 
factors,  could have a greater impact than the above-
mentioned factors on the smoking behaviors of patients 
after discharge.  Because nicotine induces dopamine 
release in the dopaminergic reward pathway [30],  
recent studies have examined the relationship of phar-
macogenetic factors such as polymorphisms in the 
dopamine-D2 receptor with nicotine dependence and 
smoking behavior [31ﾝ33].  To our knowledge,  there 
is no study that has examined the genetic eﬀects on 
smoking behavior among IHD patients.  Such studies 
would aid in advancing support for smoking cessation 
among these patients.
　 It is imperative that IHD patients permanently quit 
smoking.  Determining the long-term smoking cessation 
rate and its associated factors among patients with 
established IHD are problems that remain unresolved.
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